Processa Pharmaceuticals, Inc. Investment Warrants, Exercise Price
Processa Pharmaceuticals, Inc. (PCSA) reported Investment Warrants, Exercise Price of $2.452 for the 12-month period ending 2019-05-25, per its 10-K/A filed 2019-04-08.
Discontinued › Notes
invest:InvestmentWarrantsExercisePrice · last filed 2019-04-08
- Processa Pharmaceuticals, Inc. investment warrants, exercise price for fiscal 2019 was $2.45.
USD
| Period end | Investment Warrants, Exercise Price 0 month | Investment Warrants, Exercise Price 12 month |
|---|---|---|
| 2019-05-25 | $2.45 10-K/A · filed 2019-04-08 | |
| 2018-05-25 | $2.45 10-Q · filed 2018-11-14 |
USD/shares
| Period end | Investment Warrants, Exercise Price 0 month | Investment Warrants, Exercise Price 12 month |
|---|---|---|
| 2019-05-25 | $2.45 10-K/A · filed 2019-04-08 | |
| 2018-05-25 | $2.45 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |